TIMP1 and neuroblastoma: Similar to reports in adult cancer, high TIMP-1-expressing tumors in our small, advanced stage neuroblastoma tissue microarray (N= 20 tumors) was associated with increased adverse events and mortality (Supplementary Table 1).